Clinical Trials Directory

Trials / Unknown

UnknownNCT02120235

Investigating Lysosomal Storage Diseases in Minority Groups

Status
Unknown
Phase
Study type
Observational
Enrollment
20,000 (estimated)
Sponsor
O & O Alpan LLC · Academic / Other
Sex
All
Age
1 Day – 100 Years
Healthy volunteers
Accepted

Summary

Although lysosomal storage disorders, such as Fabry disease, Gaucher disease, and Pompe disease, represent serious challenges in the healthcare system, no study has yet investigated the prevalence of these diseases in the US. Frequently, patients show progressive worsening of symptoms for several years before they get diagnosed. Since many of these diseases can be managed therapeutically, it is important to identify and treat patients in order to avoid organ damage. The investigators aim to undertake a screening study that identifies undiagnosed patients with lysosomal storage disorders and determine the prevalence of these diseases with special focus on underrepresented minority groups.

Conditions

Timeline

Start date
2014-02-01
Primary completion
2018-02-01
Completion
2018-12-01
First posted
2014-04-22
Last updated
2017-04-04

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02120235. Inclusion in this directory is not an endorsement.